Piracetam (Epilepsy = All indications)

Table   Graphic  
individual studies
OutcomeTE95% CIn casesn exposedkPub. bias Congenital malformations All congenital malformations (majors, minors, majors and minors, or unspecified) Morrow (Piracetam) (Controls unexposed, sick), 2006 125.71[0.48; 1374.93]81not evaluable Major congenital malformations Morrow (Piracetam) (Controls unexposed, sick), 2006 125.71[0.48; 1374.93]81not evaluable Congenital heart defects Morrow (Piracetam) (Controls exposed to Lamotrigine, sick), 2006 1Out of scale142.78[2.54; 8018.04]41not evaluable Digestive system anomalies Morrow (Piracetam) (Controls exposed to Lamotrigine, sick), 2006 1Out of scale183.86[3.18; 10641.11]31not evaluable Hypospadias Morrow (Piracetam) (Controls exposed to Lamotrigine, sick), 2006 198.54[1.81; 5355.46]61not evaluable Limb defects Morrow (Piracetam) (Controls exposed to Lamotrigine, sick), 2006 1Out of scale257.80[4.22; 15744.39]21not evaluable Neural Tube Defects Morrow (Piracetam) (Controls exposed to Lamotrigine, sick), 2006 1Out of scale430.33[6.23; 29713.20]11not evaluable Oro-facial clefts Morrow (Piracetam) (Controls exposed to Lamotrigine, sick), 2006 1Out of scale430.33[6.23; 29713.20]11not evaluable0.2100.01.0

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons